SCHEDULE: Fairbairn Family Reduces Stake in IN8bio
Schedule 13D Amendment
Emily and Malcom Fairbairn have fallen below the 5% beneficial ownership threshold in IN8bio, Inc. following a significant charitable donation of shares.
Summary
- Emily and Malcom Fairbairn, along with their 2010 CRUT, filed an amendment to their Schedule 13D.
- The reporting persons transferred 724,637 shares of IN8bio common stock to a 501(c)(3) charitable foundation on May 27, 2026.
- As a result of this transfer, the reporting persons no longer beneficially own more than 5% of the company's outstanding common stock.
- Emily Fairbairn now beneficially owns 215,431 shares (2.2%), and Malcom Fairbairn owns 205,626 shares (2.1%).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting a change in personal investment holdings and charitable giving.
Positives
- The reduction in ownership is due to a charitable contribution, which is a neutral to positive event for the foundation involved.
Negatives
- The reporting persons have ceased to be major shareholders (above 5%), which may reduce their influence on corporate governance.
Risks
- The reduction in ownership stake by significant holders can sometimes be perceived as a lack of long-term confidence in the issuer's future performance.
Future Outlook
No specific forward-looking guidance regarding the company's operations was provided in this filing.
Industry Context
StockSavvy.ai notes that this filing reflects a change in shareholder composition rather than a change in the underlying business fundamentals of the biotechnology sector.
Comparison to Industry Standards
- The filing follows standard SEC disclosure requirements for individuals whose beneficial ownership drops below the 5% reporting threshold.
Stakeholder Impact
- Shareholders may note the reduction in ownership by the Fairbairn family, though the shares were transferred to a charitable entity rather than sold on the open market.
Next Steps
- No further actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 2026-01-02 | Original Schedule 13D filing date. |
| 2026-05-04 | Date of outstanding share count reference from Form 10-Q. |
| 2026-05-27 | Date of share transfer to charitable foundation and event requiring filing. |
| 2026-05-29 | Date of filing for Amendment No. 1. |
Keywords
IN8bio, IN8B, Schedule 13D, Beneficial Ownership, Charitable Donation, Equity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.